Wockhardt’s board has approved plans to raise up to Rs 150 crore by issuing securities on a private placement basis. The credit facilities committee of the board at its meeting held on May 21 has approved the raising of funds up to Rs 150 crore through issuance of rated/unrated, listed/unlisted, secured/unsecured non-convertible debentures on a private placement basis, in one or more tranches.
Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.